Lawrence Wyner, MD
Urology · Huntington, WVNPI 1790843316
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,870 of the $2,353 with a category attached, or 79.5%. 21 manufacturers reported payments, led by Johnson & Johnson at 30.1% of the total. Reporting peaked in 2022 at $1,140 and has fallen 90.8% since, to $105 in 2025. That places this record below the midpoint for urology clinicians in WV, where the typical reported total is $2,534.
Across 75 payments — averaging $31.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$708
- Astellas Pharma US Inc$401
- Endo Pharmaceuticals Inc.$274
- Convatec Inc.$240
- Sumitomo Pharma America, Inc.$186
- Comsort, Inc$100
- plus $445 from 15 others
What the payments were for
- Consulting fees$1004%
- Food & beverage$1,87079%
- Education$38316%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 13 | $708 |
| Astellas Pharma US Inc | 15 | $401 |
| Endo Pharmaceuticals Inc. | 7 | $274 |
| Convatec Inc. | 7 | $240 |
| Sumitomo Pharma America, Inc. | 9 | $186 |
| Comsort, Inc | 1 | $100 |
| Axonics, Inc. | 3 | $61 |
| Myriad Genetic Laboratories, Inc. | 3 | $50 |
| Hollister Incorporated | 2 | $49 |
| Boston Scientific | 2 | $35 |
| Urovant Sciences Inc | 2 | $31 |
| AbbVie(2 entities) | 2 | $31 |
| 180 Medical, Inc. | 1 | $28 |
| Antares Pharma, Inc. | 1 | $25 |
| Endo USA, Inc. | 1 | $25 |
| Telix Pharmaceuticals | 1 | $22 |
| Rochester Medical Corporation | 1 | $21 |
| Pfizer | 1 | $19 |
| Procept Biorobotics Corporation | 1 | $18 |
| Coloplast | 1 | $15 |
| Halozyme Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,353 in reported general payments places this provider in the 40th percentile of 67 urology providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 57 | $56,075 |
| GemtesaVibegron | 26 | $28,361 |
| Testosterone Cypionate | 82 | $5,136 |
| Tamsulosin Hcl | 205 | $2,995 |
| Tolterodine Tartrate ErTolterodine Tartrate | 14 | $2,048 |
| Estradiol | 21 | $1,695 |
| Finasteride | 92 | $1,435 |
| Trimethoprim | 13 | $848 |
| Tolterodine Tartrate | 25 | $790 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 39 | $731 |
| Oxybutynin Chloride ErOxybutynin Chloride | 34 | $706 |
| Solifenacin Succinate | 13 | $592 |
| Oxybutynin Chloride | 15 | $575 |
| NitrofurantoinNitrofurantoin Macrocrystal | 22 | $455 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 42 | $378 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $401 | $56,07557 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $186 | $28,36126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 67 urology providers in West Virginia.
Other urology in Huntington
- Stanley ZaslauHuntington$14K
- Rocco MorabitoHuntington$6K
- Amjad AlwaalHuntington$5K
- Margaret VerebHuntington$4K
- James JensenHuntington$4K
- Frederick MartinezHuntington$3K
- Justyn BlankenshipHuntington$3K
- Roger RobertsonHuntington$3K
- Rocco MorabitoHuntington$3K
- Mark ThomasHuntington$787
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.